Author: Admin

We work with a number of Bio Tech companies and over the last 12 months an increasing number of Bio Pharma companies are being funded, with increased demand comes higher valuations. Bio Pharma investment is once again main stream. Access to public markets is improving and...

We frequently field questions from startup executives who are considering selling Common Shares in Secondary Transactions. Exchanges do exist to trade equity securities in private companies are traded, but the most common Secondary Sales of Common Stock we review come in the following forms: 1. Direct...